![](/img/cover-not-exists.png)
21 The survival benefit of erlotinib in the management of advanced non-small cell lung cancer (NSCLC) in the routine clinical practice; a retrospective study
Daverede, L., Elmahdawi, N., Scott, C., Bozas, G., Upadhyay, S., Dhadda, A., Butt, M.Volume:
71
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(11)70021-6
Date:
January, 2011
File:
PDF, 34 KB
english, 2011